Table 3.
Multivariable linear regression of the entire cohort on the outcome of femoral neck bone mineral density (g/cm2) (N = 135, r2 = 0.32).
Variables | β | 95% CI | p-Value |
---|---|---|---|
Age | −0.003 | −0.005 to −0.001 | 0.001 |
Female sex | −0.067 | −0.125 to −0.008 | 0.027 |
High positive anti-CCPa | −0.049 | −0.090 to −0.008 | 0.019 |
Disease duration (years) | −0.001 | −0.003 to 0.001 | 0.303 |
BMIb | 0.007 | 0.003 to 0.010 | <0.0001 |
Frailtyc | |||
Robust | Ref | – | – |
Pre-frail | −0.074 | −0.129 to −0.020 | 0.008 |
Frail | −0.092 | −0.177 to −0.006 | 0.035 |
All variables included in the multivariate model are shown in table.
CCP: cyclic citrullinated peptide antibody; BMI: body mass index.
High positive anti-CCP defined as level three times the upper limit of normal (>60 units) based on the 2010 EULAR/ACR RA classification criteria (Aletaha et al., 2010). This threshold was used to minimize heterogeneity of this group.
BMI calculated as weight (kg) divided by height (m2).
Categories based on Fried Frailty Index (Fried et al., 2001) (score of 0 = robust; 1–2 = pre-frail; 3+ = frail).